Steven Perrin

1.2k total citations
17 papers, 656 citations indexed

About

Steven Perrin is a scholar working on Neurology, Molecular Biology and Genetics. According to data from OpenAlex, Steven Perrin has authored 17 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 7 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Steven Perrin's work include Amyotrophic Lateral Sclerosis Research (10 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Single-cell and spatial transcriptomics (3 papers). Steven Perrin is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (10 papers), Neurogenetic and Muscular Disorders Research (5 papers) and Single-cell and spatial transcriptomics (3 papers). Steven Perrin collaborates with scholars based in United States and Canada. Steven Perrin's co-authors include Fernando G. Vieira, Alan Gill, Norm Allaire, Kenneth Thompson, Joshua D. Kidd, Apinya Ngam-ek, Roy A. Fava, Jeffrey L. Browning, Jane Hunt and Beth Levine and has published in prestigious journals such as Nature Genetics, Immunity and PLoS ONE.

In The Last Decade

Steven Perrin

17 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Perrin United States 12 225 222 196 97 80 17 656
Monica Z. Wang United States 9 159 0.7× 171 0.8× 460 2.3× 77 0.8× 48 0.6× 10 942
Yumiko Azuma Japan 14 173 0.8× 105 0.5× 233 1.2× 84 0.9× 61 0.8× 33 487
Alessandra Musso Italy 14 213 0.9× 248 1.1× 178 0.9× 67 0.7× 94 1.2× 16 665
Drorit Luria Israel 19 195 0.9× 73 0.3× 393 2.0× 99 1.0× 140 1.8× 40 939
Anca Tirniceriu Germany 6 49 0.2× 178 0.8× 250 1.3× 43 0.4× 143 1.8× 6 630
Nipun A. Mistry United States 5 507 2.3× 96 0.4× 450 2.3× 346 3.6× 95 1.2× 7 852
Jordan Jones Australia 14 119 0.5× 98 0.4× 452 2.3× 152 1.6× 27 0.3× 31 923
Xianzhen Hu United States 17 296 1.3× 468 2.1× 194 1.0× 18 0.2× 138 1.7× 29 959
Bianca Miterski Germany 14 84 0.4× 160 0.7× 299 1.5× 48 0.5× 73 0.9× 19 778
Yun Hyun Huh South Korea 17 50 0.2× 82 0.4× 350 1.8× 26 0.3× 74 0.9× 29 705

Countries citing papers authored by Steven Perrin

Since Specialization
Citations

This map shows the geographic impact of Steven Perrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Perrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Perrin more than expected).

Fields of papers citing papers by Steven Perrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Perrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Perrin. The network helps show where Steven Perrin may publish in the future.

Co-authorship network of co-authors of Steven Perrin

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Perrin. A scholar is included among the top collaborators of Steven Perrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Perrin. Steven Perrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Perrin, Steven, Shafeeq Ladha, Nicholas J. Maragakis, et al.. (2024). Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial. PLoS Medicine. 21(10). e1004469–e1004469. 2 indexed citations
2.
Vieira, Fernando G., Joshua D. Kidd, Andrew Moreno, et al.. (2024). PERK modulation, with GSK2606414, Sephin1 or salubrinal, failed to produce therapeutic benefits in the SOD1G93A mouse model of ALS. PLoS ONE. 19(2). e0292190–e0292190. 1 indexed citations
3.
Vieira, Fernando G., Subhashini Venugopalan, Aren Jansen, et al.. (2022). A machine-learning based objective measure for ALS disease severity. npj Digital Medicine. 5(1). 45–45. 24 indexed citations
4.
5.
Vieira, Fernando G., Theo Hatzipetros, Kenneth Thompson, et al.. (2017). CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits. IBRO Reports. 2. 47–53. 32 indexed citations
6.
Berry, James D., Sabrina Paganoni, Nazem Atassi, et al.. (2017). Phase IIa trial of fingolimod for amyotrophic lateral sclerosis demonstrates acceptable acute safety and tolerability. Muscle & Nerve. 56(6). 1077–1084. 42 indexed citations
7.
Berry, James D., Sabrina Paganoni, Nazem Atassi, et al.. (2015). A Phase IIa Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Oral Fingolimod In Patients with Amyotrophic Lateral Sclerosis (ALS) (P7.067). Neurology. 84(14_supplement). 1 indexed citations
8.
Vieira, Fernando G., Joshua D. Kidd, Kenneth Thompson, et al.. (2015). Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS. PLoS ONE. 10(8). e0135570–e0135570. 64 indexed citations
9.
Vieira, Fernando G., Joshua D. Kidd, Beth Levine, et al.. (2014). Dexpramipexole Is Ineffective in Two Models of ALS Related Neurodegeneration. PLoS ONE. 9(12). e91608–e91608. 23 indexed citations
10.
Lincecum, John, Fernando G. Vieira, Monica Z. Wang, et al.. (2010). From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nature Genetics. 42(5). 392–399. 96 indexed citations
11.
Gill, Alan, Joshua D. Kidd, Fernando G. Vieira, Kenneth Thompson, & Steven Perrin. (2009). No Benefit from Chronic Lithium Dosing in a Sibling-Matched, Gender Balanced, Investigator-Blinded Trial Using a Standard Mouse Model of Familial ALS. PLoS ONE. 4(8). e6489–e6489. 66 indexed citations
12.
Shearstone, Jeffrey R., et al.. (2006). Accurate and precise transcriptional profiles from 50 pg of total RNA or 100 flow-sorted primary lymphocytes. Genomics. 88(1). 111–121. 8 indexed citations
13.
Browning, Jeffrey L., Norm Allaire, Apinya Ngam-ek, et al.. (2005). Lymphotoxin-β Receptor Signaling Is Required for the Homeostatic Control of HEV Differentiation and Function. Immunity. 23(5). 539–550. 213 indexed citations
14.
Shearstone, Jeffrey R., Norm Allaire, Chunhua Yang, et al.. (2004). Application of functional genomic technologies in a mouse model of retinal degeneration. Genomics. 85(3). 309–321. 5 indexed citations
15.
Shearstone, Jeffrey R., et al.. (2002). Nondestructive Quality Control for Microarray Production. BioTechniques. 32(5). 1051–1057. 13 indexed citations
16.
Perrin, Steven, Celeste B. Rich, Shirley M. Morris, Phillip J. Stone, & Judith Ann Foster. (1999). The Zebrafish Swimbladder: A Simple Model for Lung Elastin Injury and Repair. Connective Tissue Research. 40(2). 105–112. 16 indexed citations
17.
Perrin, Steven & Judith Ann Foster. (1997). Developmental Regulation of Elastin Gene Expression. Critical Reviews in Eukaryotic Gene Expression. 7(1-2). 1–10. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monica Z. Wang Breakdown of academic impact, for papers by Yumiko Azuma Breakdown of academic impact, for papers by Alessandra Musso Breakdown of academic impact, for papers by Drorit Luria Breakdown of academic impact, for papers by Anca Tirniceriu Breakdown of academic impact, for papers by Nipun A. Mistry Breakdown of academic impact, for papers by Jordan Jones Breakdown of academic impact, for papers by Xianzhen Hu Breakdown of academic impact, for papers by Bianca Miterski Breakdown of academic impact, for papers by Yun Hyun Huh
Rankless by CCL
2026